AcureOmics AB is devoted to personalised healthcare, biofluid profiling and systems biology including “omics” research. These fields hold enormous potential for enhancing the drug discovery and development processes in the pharmaceutical industry and opening up new possibilities for diagnostic approaches and personalized medicine in the healthcare field.
AcureOmics has several projects and collaborations to find novel indicators for various diseases. A number of biomarker candidates suitable for further study as valid diagnostic discriminators to predict disease risk have been identified and IPR is being pursued.
AcureOmics also offer the following CRO services:
- Analysis with GC-MS, LC-MS, NMR and/or other profiling techniques for a wide range of samples.
- Planning of metabonomics/metabolomics studies based on design of experimental methodology to ensure maximum information content with optimal use of resources.
- Multivariate data analysis and statistical modeling of the complex data structures that result from metabonomics/metabolomics studies.
Johan Trygg 1, Rasmus Madsen 1, Jon Gabrielsson 2, Thomas Moritz 3 and Torbjörn Lundstedt 4
1. Research Group for Chemometrics, Umeå University, SE-901 87 Umeå, Sweden
2. AcureOmics AB, Umeå Biotech Incubator, Tvistev. 48, SE-907 36 Umeå, Sweden
3. Umeå Plant Science Centre, SLU, SE-901 83 Umeå, Sweden
4. AcurePharma AB, Ulleråkersvägen 42A, SE-756 43 Uppsala, Sweden
